Download PDF
CC BY-NC-ND 4.0 · Journal of Gastrointestinal Infections 2023; 13(01): 034-037
DOI: 10.1055/s-0043-1768144
Brief Report

Infections in Patients with Severe Alcoholic Hepatitis: A Retrospective Study

Mayank Jain 
1   Arihant Hospital and Research Centre, Indore, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction Severe alcoholic hepatitis (SAH) is the severest type of alcohol-related liver disease and is fraught with risk of infectious complications. The present study was done to determine the frequency and types of infections noted in patients with SAH at baseline evaluation.

Methods This is a retrospective analysis of patients with alcoholic hepatitis treated at our center between 2019 and 2022. Details of age, gender, baseline laboratory parameters, and clinical presentation were noted. All patients were screened for infections to ascertain the suitability for steroid use as per protocol. Diagnosis of infections was done as per the North American Consortium for the Study of End Stage Liver Disease (NACSELD) criteria. In culture-positive infections, the details of the microorganisms that were isolated and antibiotic susceptibility patterns were recorded.

Results A total of 66 patients with SAH formed the study cohort (median age: 42 years; 100% males). The majority of them had underlying cirrhosis (33 [50%]) and 26 had acute-on-chronic liver failure. Twenty-eight (42.4%) cases had bacterial infections. Spontaneous bacterial peritonitis (10 [35.7%]) was the commonest infection, followed by urinary tract infection (8 [28.5%]), lower respiratory infections (7 [25%]), and skin infections (3 [10.7%]). Culture positivity was noted in 12 cases (42.9%). The commonest organism cultured was Escherichia coli (6 cases), followed by Klebsiella pneumoniae (cases). Multidrug-resistant (MDR) infections were noted in nine (13.6%) cases. Two patients had tuberculosis.

Conclusion In all, 42.4% of patients with SAH had bacterial infections at baseline evaluation. Spontaneous bacterial peritonitis was the commonest infection. MDR bacterial infections were noted in nine cases (13.6%).

Keywords

alcoholic cirrhosis - alcoholic hepatitis - Asia - cirrhosis - peritonitis

Consent and Ethical Clearance

Ethical clearance was obtained via letter no. AHRC/IEC/2022/6. The need for informed consent was waived due to the retrospective nature of the study.


Authors' Contribution

All the authors contributed equally to the article.


Data Availability

Data can be shared by the author on a reasonable request.




Publication History

Received: 11 June 2023

Accepted: 20 February 2023

Article published online:
22 September 2023

© 2023. Gastroinstestinal Infection Society of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Taneja SK, Dhiman RK. Prevention and management of bacterial infections in cirrhosis. Int J Hepatol 2011; 2011: 784540
    CrossrefPubMedSearch in Google Scholar
  • 2 Baijal R, Praveenkumar HR, Amarapurkar DN, Nagaraj K, Jain M. Prevalence of tuberculosis in patients with cirrhosis of liver in western India. Trop Doct 2010; 40 (03) 163-164
    CrossrefPubMedSearch in Google Scholar
  • 3 Ray G, Manjubhargav P. Clinical presentation and mortality determinants of alcohol-related liver disease: a single-center experience of the rising menace from Eastern India. Inflamm Intest Dis 2019; 4 (03) 104-114
    CrossrefPubMedSearch in Google Scholar
  • 4 Kaur B, Rosenblatt R, Sundaram V. Infections in alcoholic hepatitis. J Clin Transl Hepatol 2022; 10 (04) 718-725
    CrossrefPubMedSearch in Google Scholar
  • 5 Karakike E, Moreno C, Gustot T. Infections in severe alcoholic hepatitis. Ann Gastroenterol 2017; 30 (02) 152-160
    PubMedSearch in Google Scholar
  • 6 Crabb DW, Bataller R, Chalasani NP. et al; NIAAA Alcoholic Hepatitis Consortia. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia. Gastroenterology 2016; 150 (04) 785-790
    CrossrefPubMedSearch in Google Scholar
  • 7 O'Shea RS, Dasarathy S, McCullough AJ. Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 2010; 51 (01) 307-328
    CrossrefPubMedSearch in Google Scholar
  • 8 Sarin SK, Kedarisetty CK, Abbas Z. et al; APASL ACLF Working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int 2014; 8 (04) 453-471
    CrossrefPubMedSearch in Google Scholar
  • 9 Vergis N, Atkinson SR, Thursz MR. Assessment and Management of Infection in Alcoholic Hepatitis. Semin Liver Dis 2020; 40 (01) 11-19
    Thieme ConnectPubMedSearch in Google Scholar
  • 10 Bajaj JS, O'Leary JG, Reddy KR. et al; NACSELD. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 2012; 56 (06) 2328-2335
    CrossrefPubMedSearch in Google Scholar
  • 11 Magiorakos AP, Srinivasan A, Carey RB. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18 (03) 268-281
    CrossrefPubMedSearch in Google Scholar
  • 12 Louvet A, Wartel F, Castel H. et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009; 137 (02) 541-548
    CrossrefPubMedSearch in Google Scholar
  • 13 Karakike E, Trepo E, Hites M. et al. Infections in patients with severe alcoholic hepatitis: a cohort study. Paper presented at: European Congress of Clinical Microbiology and Infectious Diseases. 25–28 April, 2015; Copenhagen, Denmark
  • 14 Michelena J, Altamirano J, Abraldes JG. et al. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology 2015; 62 (03) 762-772
    CrossrefPubMedSearch in Google Scholar
  • 15 Altamirano J, Miquel R, Katoonizadeh A. et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 2014; 146: 1231-1239.e1–e6
    CrossrefPubMedSearch in Google Scholar
  • 16 Hmoud BS, Patel K, Bataller R, Singal AK. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver Int 2016; 36 (05) 721-728
    CrossrefPubMedSearch in Google Scholar
  • 17 Thursz MR, Richardson P, Allison M. et al; STOPAH Trial. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 2015; 372 (17) 1619-1628
    CrossrefPubMedSearch in Google Scholar
  • 18 Baijal R, Amarapurkar D, Praveen Kumar HR. et al. A multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver. Indian J Gastroenterol 2014; 33 (04) 336-342
    CrossrefPubMedSearch in Google Scholar
  • 19 Jain M, Varghese J, Michael T. et al. An insight into antibiotic resistance to bacterial infection in chronic liver disease. J Clin Exp Hepatol 2017; 7 (04) 305-309
    CrossrefPubMedSearch in Google Scholar
  • 20 Kumar K, Mohindra S, Raj M, Choudhuri G. Procalcitonin as a marker of sepsis in alcoholic hepatitis. Hepatol Int 2014; 8 (03) 436-442
    CrossrefPubMedSearch in Google Scholar